Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Chen

Showing results (361-370 of 477) with videos related to

Pageof 48
Sort By:
Cell Metabolism|December 14, 2017
LEAP2 Is an Endogenous Antagonist of the Ghrelin ReceptorXuecai Ge, Hong Yang, Maria A Bednarek, et al.
Molecular Pharmacology|August 4, 2012
Identification and pharmacological characterization of multiple allosteric binding sites on the free fatty acid 1 receptorDaniel C-H Lin, Qi Guo, Jian Luo, et al.
Journal of Biomedical Science|May 31, 2023
A non-genetic engineering platform for rapidly generating and expanding cancer-specific armed T cellsYi-Jou Chen, Michael Chen, Tian-Lu Cheng, et al.
Biomaterials Science|November 26, 2021
A novel anti-tumor/anti-tumor-associated fibroblast/anti-mPEG tri-specific antibody to maximize the efficacy of mPEGylated nanomedicines against fibroblast-rich solid tumorMichael Chen, Ming-Thau Sheu, Tian-Lu Cheng, et al.
Cancer Research|December 18, 2004
Estrogen receptor genotypes and haplotypes associated with breast cancer riskBert Gold, Francis Kalush, Julie Bergeron, et al.
MMWR. Morbidity and Mortality Weekly Report|August 22, 2024
Vital Signs: Trends and Disparities in Childhood Vaccination Coverage by Vaccines for Children Program Eligibility - National Immunization Survey-Child, United States, 2012-2022Madeleine R Valier, David Yankey, Laurie D Elam-Evans, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 23, 2019
First-in-Class, First-in-Human Study Evaluating LV305, a Dendritic-Cell Tropic Lentiviral Vector, in Sarcoma and Other Solid Tumors Expressing NY-ESO-1Neeta Somaiah, Matthew S Block, Joseph W Kim, et al.
Einstein (Sao Paulo, Brazil)|July 12, 2013
Treatment of breast cancer patients from a public healthcare system in a private center: costs of care for a pilot public-private partnership in oncologyRafael Aliosha Kaliks, Lucíola de Barros Pontes, Cinthia Leite Frizzera Borges Bognar, et al.
Journal of Neurointerventional Surgery|April 30, 2025
Commentary on the River Stent Trial: Venous Sinus Stenting is Safe and Effective and can be Fully Evaluated Using Noninvasive MethodsMatthew Robert Amans, Michael Levitt, Joshua A Hirsch, et al.
Plos One|October 12, 2012
A potent class of GPR40 full agonists engages the enteroinsular axis to promote glucose control in rodentsJian Luo, Gayathri Swaminath, Sean P Brown, et al.
Pageof 48

Showing results (361-370 of 477) with videos related to

Sort By:
Pageof 48
Cell Metabolism|December 14, 2017
LEAP2 Is an Endogenous Antagonist of the Ghrelin ReceptorXuecai Ge, Hong Yang, Maria A Bednarek, et al.
Molecular Pharmacology|August 4, 2012
Identification and pharmacological characterization of multiple allosteric binding sites on the free fatty acid 1 receptorDaniel C-H Lin, Qi Guo, Jian Luo, et al.
Journal of Biomedical Science|May 31, 2023
A non-genetic engineering platform for rapidly generating and expanding cancer-specific armed T cellsYi-Jou Chen, Michael Chen, Tian-Lu Cheng, et al.
Biomaterials Science|November 26, 2021
A novel anti-tumor/anti-tumor-associated fibroblast/anti-mPEG tri-specific antibody to maximize the efficacy of mPEGylated nanomedicines against fibroblast-rich solid tumorMichael Chen, Ming-Thau Sheu, Tian-Lu Cheng, et al.
Cancer Research|December 18, 2004
Estrogen receptor genotypes and haplotypes associated with breast cancer riskBert Gold, Francis Kalush, Julie Bergeron, et al.
MMWR. Morbidity and Mortality Weekly Report|August 22, 2024
Vital Signs: Trends and Disparities in Childhood Vaccination Coverage by Vaccines for Children Program Eligibility - National Immunization Survey-Child, United States, 2012-2022Madeleine R Valier, David Yankey, Laurie D Elam-Evans, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 23, 2019
First-in-Class, First-in-Human Study Evaluating LV305, a Dendritic-Cell Tropic Lentiviral Vector, in Sarcoma and Other Solid Tumors Expressing NY-ESO-1Neeta Somaiah, Matthew S Block, Joseph W Kim, et al.
Einstein (Sao Paulo, Brazil)|July 12, 2013
Treatment of breast cancer patients from a public healthcare system in a private center: costs of care for a pilot public-private partnership in oncologyRafael Aliosha Kaliks, Lucíola de Barros Pontes, Cinthia Leite Frizzera Borges Bognar, et al.
Journal of Neurointerventional Surgery|April 30, 2025
Commentary on the River Stent Trial: Venous Sinus Stenting is Safe and Effective and can be Fully Evaluated Using Noninvasive MethodsMatthew Robert Amans, Michael Levitt, Joshua A Hirsch, et al.
Plos One|October 12, 2012
A potent class of GPR40 full agonists engages the enteroinsular axis to promote glucose control in rodentsJian Luo, Gayathri Swaminath, Sean P Brown, et al.
Pageof 48